Zejuan Li

Research activity per year

Filter

2022

Revision of RUNX1 variant curation rules
the Myeloid Malignancy Variant Curation Expert Panel, Aug 23 2022, In: Blood Advances. 6, 16, p. 4726-4730 5 p.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access

10 Scopus citations
2018
Erratum: Publisher Correction: miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia (Nature communications (2012) 3 (688))
Li, Z., Huang, H., Chen, P., He, M., Li, Y., Arnovitz, S., Jiang, X., He, C., Hyjek, E., Zhang, J., Zhang, Z., Elkahloun, A., Cao, D., Shen, C., Wunderlich, M., Wang, Y., Neilly, M. B., Jin, J., Wei, M. & Lu, J. & 10 others, Valk, P. J. M., Delwel, R., Lowenberg, B., Le Beau, M. M., Vardiman, J., Mulloy, J. C., Zeleznik-Le, N. J., Liu, P. P., Zhang, J. & Chen, J., Apr 10 2018, In: Nature Communications. 9, p. 16192 1 p., 16192.
Research output: Contribution to journal › Comment/debate › peer-review
1 Scopus citations

Zejuan Li, MD, PhD, FACMG